Effects of pertussis toxin, dibutyryl-cyclic-amp, bromo-cyclic-amp and forskolin on the behavioural and electrocortical power spectrum changes induced by microinfusion of interleukin-2 into the locus coeruleus

References

• Aghajanian G. K., Wang Y. Y. Pertussis toxin blocks the outward currents evoked by opiate and alpha-2 agonists in locus coeruleus neurons. Brain Research 1986; 371: 390–394
   PubMed Web of Science ®Google Scholar
• Aranjo D. M., Lapchak P. A., Callier B., Quiran R. Localization of interleukin-2 immunoactivity and interleukin-2 receptors in the rat brain. Interaction with the cholinergic system. Brain Research 1989; 498: 257–266
   PubMed Web of Science ®Google Scholar
• Bagetta G., De Sarro G. B., Sakurada S., Rispoli V., Nistico G. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats. British Journal of Pharmacology 1990; 101: 655–661
   PubMed Web of Science ®Google Scholar
• Beckner S. K., Farrar W. L. Interleukin 2 modulation of adenylate cyclase; potential role of protein kinase C. Journal of Biological Chemistry 1986; 261: 3043–3047
   PubMed Web of Science ®Google Scholar
• Beckner S. K., Farrar W. L. Potentiation of lymphokines-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase. Journal of Immunology 1988; 140: 208–214
   PubMed Web of Science ®Google Scholar
• Besedovsky H. O., Del Rey A. E., Sorkin E., Da Prada M., Burri R., Honegger C. The immune response evokes changes in brain noradrenergic neurons. Science 1983; 221: 564–566
   PubMed Web of Science ®Google Scholar
• Besedovsky H. O., Del Rey A. E., Sorkin E. Immune-neuroendocrine interactions. Journal of Immunology 1985; 135: 750s–754s
   PubMed Web of Science ®Google Scholar
• Bindoni M., Parciavalle V., Beutta F., Belluardo N., Diamantstein T. Interleukin-2 modifies the bioelectric activity of some neurosecretory nuclei in the rat hypothalamus. Brain Research 1988; 462: 10–14
   PubMed Web of Science ®Google Scholar
• Blalock J. E., Smith E. M. Human leukocyte interferon (Hu-IFN-alpha): Potent endorphin-like opioid activity. Biochemical and Biophysical Research Communications 1981b; 101: 402–478
   Web of Science ®Google Scholar
• Blalock J. E., Smith E. M. A complete regulatory loop between the immune and neuroendocrine sistems. Federation proceedings 1985; 44: 108–111
   PubMedGoogle Scholar
• Bourne H. R. Interleukin-2 and GTP binding in lymphocytes. Nature 1987; 326: 833
   PubMed Web of Science ®Google Scholar
• Bricolo A., Turazzi S., Faccioli F., Odorizzi F., Sciarretta C., Erculiani P. Clinical application of compressed spectral array in long-term EEG monitoring of comatose patients. Electroencephalography and Clinical Neurophysiology 1978; 45: 211–225
   PubMedGoogle Scholar
• Cassel D., Pfeuffer T. Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide binding protein of the adenylate cyclase system. Proceedings of the National Academy of Scienecs USA 1978; 75: 2669–2673
   PubMed Web of Science ®Google Scholar
• Dafny N. Interferon modifies EEG and EEG-like activity recorded from sensory, motor and limbic system structures in freely behaving rats. Neurotoxicology 1983; 4: 235–240
   PubMed Web of Science ®Google Scholar
• Dafny N. Interferon as a candidate endogenous substance preventing tolerance and dependence to brain opioids. Progress in Neuropsychopharmacology and Biological Psychiatry 1984; 8: 351–357
   PubMed Web of Science ®Google Scholar
• Dafny N., Prieto-Gomez B., Reyes-Vazquez C. Does the immune system communicate with the central nervous system. Journal of Neuroimmunology 1985; 9: 1–12
   PubMed Web of Science ®Google Scholar
• De Sarro G. B., Ascioti C., Audino M. G., Rispoli V., Nistico G. Behavioral and ECoG spectrum changes induced by intracerebral microinfusion of interferons and interleukin-2 in rats are antagonized by naloxone. Interactions among Central Nervous System, Neuroendocrine and Immune Systems, J. W. Hadden, K. Masek, G. Nistico. Milan Pythagora Press, Rome 1989a; 351–356
   Google Scholar
• De Sarro G. B., Ascioti C., Froio F., Libri V., Nistico G. Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha-1 and alpha-2-adrenoceptors affect sleep and arousal mechanisms. British Journal of Pharmacology 1987; 90: 675–685
   PubMed Web of Science ®Google Scholar
• De Sarro G. B., Bagetta G., Ascioti C., Libri V., Nistico G. Effects of pertussis toxin on the behavioral and ECoG spectrum changes induced by clonidine and yohimbine after their microinfusion into the locus coeruleus. British Journal of Pharmacology 1989b; 96: 59–64
   PubMed Web of Science ®Google Scholar
• De Sarro G. B., Masuda Y., Ascioti C., Audino M. G., Nistico G. Behavioral and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin-2 in rats are antagonized by naloxone. Neuropharmacology 1990; 29: 167–179
   PubMed Web of Science ®Google Scholar
• De Sarro G. B., Sakurada S., Bagetta G., Ascioti C., Audino M. G., Rispoli V., Nistico G. Behavioral and ECoG spectrum power effects induced by microinfusion of compounds acting at different opioid receptors into the locus coeruleus. Neuroscience Letters 1988; 33: 74S
   Google Scholar
• Dinarello C. A. Multiple biological properties of recombinant human interleukin-1 (B). Immunology 1986; 178: 301–315
   Google Scholar
• Evans S. W., Beckner S. K., Farrar W. L. Stimulation of specific GTP binding and hydrolysis activities in lymphocyte membrane by IL-2. Nature 1987; 325: 166–167
   PubMed Web of Science ®Google Scholar
• Farrar W. L., Anderson W. B. Interleukin-2 stimulation of protein kinase C plasma membrane association. Nature 1985; 315: 233–235
   PubMed Web of Science ®Google Scholar
• Farrar W. L., Hill J. M., Harel-Bellan A., Vinocur M. The immune logical brain. Immunological Reviews 1987a; 100: 361–378
   PubMed Web of Science ®Google Scholar
• Farrar W. L., Kilian P., Hill J. M., Ruff M. R., Pert C. B. Visualization of cytokines and virus receptor common to the immune and nervous system. Lymphokine Research 1987b; 6: 29–36
   PubMedGoogle Scholar
• Fent K., Zbinden G. Toxicity of interferon and interleukin. Trends in Pharmacological Sciences 1987; 8: 100–105
   Web of Science ®Google Scholar
• Gelfand E. W., Mills G. B., Cheung R. K., Lee J. W. W., Grinstein S. Transmembrane ion fluxes during activation of human T lymphocytes: role of Ca2+, Na+/K+ exchange and phospholipid turnover. Immunological Reviews 1987; 95: 59–74
   PubMed Web of Science ®Google Scholar
• Hadden J. W., Masek K., Nistico G. Interactions among central nervous system, neuroendocrine and immune systems. Pythagora Press, Rome, Milan 1989
   Google Scholar
• Jakobs K. M., Aktories K., Schultz G. Mechanism of pertussis toxin action on the adenylate cyclase system. European Journal of Biochemistry 1984; 140: 177–181
   PubMedGoogle Scholar
• Kozumbo W. J., Harris D. T., Gromkowski S., Cerottini J. C., Ceruti P. A. Molecular mechanisms involved in T cell activation. Journal of Immunology 1987; 138: 606–612
   PubMedGoogle Scholar
• Krueger J. M., Walter C., Dinarello C. A., Wolff S. M., Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). American Journal of Physiology 1984; 246: R994–R999
   PubMed Web of Science ®Google Scholar
• Le Grue S. J. Interleukin-2 stimulus-response coupling is calcium independent. Lymphokine Research 1987; 6: 1–11
   PubMedGoogle Scholar
• Le Grue S. J. Does interleukin-2 stimulus-response coupling result in generation of intracellular second messengers. Lymphokine Research 1988; 7: 187–200
   PubMedGoogle Scholar
• Merrill J. E. Macroglia: neural cells responsive to lymphokines and growth factors. Immunology Today 1987; 8: 146–150
   PubMedGoogle Scholar
• Merrill J. E. Lymphokines, Monokines and Glial Cells. Proceedings in Neuroendocrinimmunology 1988; 1: 13–14
   Google Scholar
• Mier J. M., Larry M. S., Allegretta M., Boone T., Bernheim H. A., Dinarello C. A. Dissimilarities between purified human interleukin-1 and recombinant human interleukin-2 in the induction of fever, brain prostaglandin, and acute-phase protein synthesis. Journal of Biologicial Response Modifier 1985; 4: 35–45
   PubMedGoogle Scholar
• Mills G. B., Cheung R. K., Grinstein S., Gelfand E. W. Increase in Cytosolic free calcium concentrations is an intracellular messangers for the production of IL-2 but not for expression of IL-2 receptor. Journal of Immunology 1985a; 134: 1640–1643
   PubMed Web of Science ®Google Scholar
• Mills G. B., Cragoe E. J., Jr, Gelfand E. W., Grinstein S. Interleukin-2 induces a rapid increase in intracellular pH through activation of a Na+/H+ antiport. Cytoplasmic alkalinization is not required for lymphocyte proliferation. Journal of Biological Chemistry 1985b; 260: 12500–12507
   PubMed Web of Science ®Google Scholar
• Mills G. B., Steward D. J., Mellors A., Gelfand E. W. IL-2 does not induce phosphatidylino-sitol hydrolysis in activated T cells. Journal of Immunology 1986; 136: 3019–3024
   PubMed Web of Science ®Google Scholar
• Nistico G., De Sarro G. B., Rotiroti D., Melchiorri P., Erspamer V. Comparative effects of B-endorphin and dermorphin on behavior, electrocortical activity and spectrum power in chicks after intraventricular administration. Research Communications in Psychology, Psychiatry and Behavior 1981; 6: 351–364
   Google Scholar
• Nistico G., Rotiroti D., Naccari F., De Sarro G. B., Marmo E. Effects of intraventricular beta-endorphin and D-ala-methionine, enkephalinamide on behavior, spectrum power of electrocortical activity and body temperature in rats. Research Communications in Chemical Pathology and Pharmacology 1980; 28: 295–308
   PubMedGoogle Scholar
• Paxinos F., Watson C. The Rat Brain in Stereotaxic Coordinates. Academic Press, London 1982
   Google Scholar
• Reyes-Vazquez C., Prieto-Gomez B., Georgiades J. A., Dafny N. Alpha and gamma interferon effects on cortical and hippocampal neurons: microiontophoretic application and single cell recording. International Journal of Neuroscience 1984; 25: 113–121
   PubMed Web of Science ®Google Scholar
• Rossio J. L., Ruscetti F. W., Farrar W. L. Ligand-specific calcium mobilization in IL-2 and IL-3 dependent cell lines. Lymphokine Research 1986; 5: 163–174
   PubMedGoogle Scholar
• Seamon K. B., Daly J. W. Forskolin: its biological and chemical properties. Advances in Cyclic Nucleotide Research 1986; 20: 1–150
   Google Scholar
• Smith K. A. Interleukin-2. Annual Reviews of Immunology 1984; 2: 319–333
   PubMed Web of Science ®Google Scholar
• Smith K. A. The two-chain structure of high-affinity IL-2 receptors. Immunology Today 1987; 8: 11–13
   PubMedGoogle Scholar
• Smith K. A. Interleukin-2: inception, impact, and implications. Science 1988; 240: 1169–1176
   PubMed Web of Science ®Google Scholar
• Smith K. A. Interleukin-2. Scientific American 1990; 262: 26–33
   Web of Science ®Google Scholar
• Tallarida R. J., Murray R. B. Manual of Pharmacological Calculations with Computer Programs. Springer-Verlag, Berlin 1981
   Google Scholar
• Tashigawa K., Wang H. M., Kato K., Smith K. A. Interleukin-2 high-affinity receptor expression requires two distinct binding proteins. Journal of Experimental Medicine 1987; 165: 223–238
   PubMed Web of Science ®Google Scholar